Using a retrospective, phenotype‐first approach, we recruited patients of European ancestry with IBD and a history of severe myelosuppression and showed that carriage of a loss of function NUDT15 variant was associated with a 27‐fold increased risk of myelosuppression [14]. Here, NUDT15 is linked to inflammatory bowel disease.